Pro Medicus Ltd
PME
Company Profile
Business description
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.
Contact
450 Swan Street
RichmondVIC3121
AUST: +61 394298800
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
30 June 2025
Employees
75
Stocks News & Analysis
stocks
Should you avoid this highflying ASX share?
A sound business model but the shares are expensive.
personal-finance
Bookworm: A timely reminder of what can drive a market reversal
David Dreman sought to beat the market by going against the crowd. The mechanisms behind that could explain Nvidia's recent fall.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,586.70 | 15.30 | 0.18% |
| CAC 40 | 7,869.37 | 4.93 | 0.06% |
| DAX 40 | 24,136.54 | 137.37 | 0.57% |
| Dow JONES (US) | 41,859.09 | 1.35 | -0.00% |
| FTSE 100 | 8,774.42 | 35.16 | 0.40% |
| HKSE | 23,601.26 | 56.95 | 0.24% |
| NASDAQ | 18,925.73 | 53.09 | 0.28% |
| Nikkei 225 | 37,160.47 | 174.60 | 0.47% |
| NZX 50 Index | 12,596.50 | 65.75 | -0.52% |
| S&P 500 | 5,842.01 | 2.60 | -0.04% |
| S&P/ASX 200 | 8,360.90 | 12.20 | 0.15% |
| SSE Composite Index | 3,348.37 | 31.82 | -0.94% |